These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30059060)

  • 21. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
    Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL
    Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea.
    Sun H; Palcza J; Card D; Gipson A; Rosenberg R; Kryger M; Lines C; Wagner JA; Troyer MD
    J Clin Sleep Med; 2016 Jan; 12(1):9-17. PubMed ID: 26194728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypnotics with novel modes of action.
    Hoyer D; Allen A; Jacobson LH
    Br J Clin Pharmacol; 2020 Feb; 86(2):244-249. PubMed ID: 31756268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of insomnia.
    Passarella S; Duong MT
    Am J Health Syst Pharm; 2008 May; 65(10):927-34. PubMed ID: 18463341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update of management of insomnia in patients with chronic orofacial pain.
    Almoznino G; Haviv Y; Sharav Y; Benoliel R
    Oral Dis; 2017 Nov; 23(8):1043-1051. PubMed ID: 28075519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.
    Atkin T; Comai S; Gobbi G
    Pharmacol Rev; 2018 Apr; 70(2):197-245. PubMed ID: 29487083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy of insomnia.
    Ioachimescu OC; El-Solh AA
    Expert Opin Pharmacother; 2012 Jun; 13(9):1243-60. PubMed ID: 22578014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep and chronic obstructive pulmonary disease.
    Kutty K
    Curr Opin Pulm Med; 2004 Mar; 10(2):104-12. PubMed ID: 15021179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment options for insomnia.
    Ramakrishnan K; Scheid DC
    Am Fam Physician; 2007 Aug; 76(4):517-26. PubMed ID: 17853625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New and emerging pharmacotherapeutic approaches for insomnia.
    Neubauer DN
    Int Rev Psychiatry; 2014 Apr; 26(2):214-24. PubMed ID: 24892896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and mechanisms of behavioral therapy components for insomnia coexisting with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
    Kapella MC; Herdegen JJ; Laghi F; Steffen AD; Carley DW
    Trials; 2016 May; 17(1):258. PubMed ID: 27215949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep disorders and their management in patients with COPD.
    Sharafkhaneh A; Jayaraman G; Kaleekal T; Sharafkhaneh H; Hirshkowitz M
    Ther Adv Respir Dis; 2009 Dec; 3(6):309-18. PubMed ID: 19880428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Appropriate Use and Abuse of Sedative-Hypnotic Drugs].
    Zheng JW; Meng SQ; Liu WY; Chang XW; Shi J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):231-239. PubMed ID: 36949678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2018 Jun; 13(2):263-270. PubMed ID: 29759276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders.
    Bruni O; Angriman M; Melegari MG; Ferri R
    Expert Opin Pharmacother; 2019 Dec; 20(18):2257-2271. PubMed ID: 31638842
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort.
    Nishimura S; Nakao M
    J Med Econ; 2018 Jul; 21(7):698-703. PubMed ID: 29667471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suvorexant: scientifically interesting, utility uncertain.
    Keks NA; Hope J; Keogh S
    Australas Psychiatry; 2017 Dec; 25(6):622-624. PubMed ID: 28994603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.